The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
Open accessAbstract
Background Patients with coronavirus disaese 2019 (COVID-19) can develop a cytokine release syndrome that eventually leads to acute respiratory distress syndrome requiring invasive mechanical ventilation (IMV). Because IL-6 is a relevant cytokine in acute respiratory distress syndrome, the blockade of its receptor with tocilizumab (TCZ) could reduce mortality and/or morbidity in severe COVID-19. Objective We sought to determine whether baseline IL-6 serum levels can predict the need for IMV and the response to TCZ. Methods A retrospective observational study was performed in hospitalized patients diagnosed with COVID-19. Clinical information and laboratory findings, including IL-6 levels, were collected approximately 3 and 9 days after admission to be matched with preadministration and postadministration of TCZ. Multivariable logistic and linear regressions and survival analysis were performed depending on outcomes: need for IMV, evolution of arterial oxygen tension/fraction of inspired oxygen ratio, or mortality. Results One hundred forty-six patients were studied, predominantly males (66%); median age was 63 years. Forty-four patients (30%) required IMV, and 58 patients (40%) received treatment with TCZ. IL-6 levels greater than 30 pg/mL was the best predictor for IMV (odds ratio, 7.1; P < .001). Early administration of TCZ was associated with improvement in oxygenation (arterial oxygen tension/fraction of inspired oxygen ratio) in patients with high IL-6 (P = .048). Patients with high IL-6 not treated with TCZ showed high mortality (hazard ratio, 4.6; P = .003), as well as those with low IL-6 treated with TCZ (hazard ratio, 3.6; P = .016). No relevant serious adverse events were observed in TCZ-treated patients. Conclusions Baseline IL-6 greater than 30 pg/mL predicts IMV requirement in patients with COVID-19 and contributes to establish an adequate indication for TCZ administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858
Norelli, M., Camisa, B., Barbiera, G., Falcone, L., Purevdorj, A., Genua, M., Sanvito, F., Ponzoni, M., Doglioni, C., Cristofori, P., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0036-4 · Cited by 1,406
Cited by
Lamers, M. M., & Haagmans, B. L. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00713-0 · Cited by 983
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Peluso, M. J., Lu, S., Tang, A. F., Durstenfeld, M. S., Ho, H.-E., Goldberg, S. A., Forman, C. A., Munter, S. E., Hoh, R., Tai, V., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab490 · Cited by 320
Metadata
- Authors
- Galván-Román, J. M., Rodríguez-García, S. C., Roy-Vallejo, E., Marcos-Jiménez, A., Sánchez-Alonso, S., Fernández-Díaz, C., Alcaraz-Serna, A., Mateu-Albero, T., Rodríguez-Cortes, P., Sánchez-Cerrillo, I., Esparcia, L., Martínez-Fleta, P., López-Sanz, C., Gabrie, L., del Campo Guerola, L., Suárez-Fernández, C., Ancochea, J., Canabal, A., Albert, P., Rodríguez-Serrano, D. A., Aguilar, J. M., del Arco, C., de los Santos, I., García-Fraile, L., de la Cámara, R., Serra, J. M., Ramírez, E., Alonso, T., Landete, P., Soriano, J. B., Martín-Gayo, E., Fraile Torres, A., Zurita Cruz, N. D., García-Vicuña, R., Cardeñoso, L., Sánchez-Madrid, F., Alfranca, A., Muñoz-Calleja, C., González-Álvaro, I., Alvarado, T., Martínez, P., Javier de la Cuerda Llorente, F., Arco, C. D., Aguilar, J. M., Villalba, N., Negro, M., Contreras, E., Rey, A. D., Santiago, C., Junquera, M., Caminero, R., Val, F. J., González, S., Caño, M., López, I., von Wernitz, A., Retana, B., Guerra, I., Sorando, J., Chao, L., Cárdenas, M. J., Espiga, V., Chicharro, P., Rodríguez, P., Alday, I. H., Sampedro, M., Prada, J., Aldama, E. R., Real, Y., Caldas, M., Casabona, S., Lanas-Gimeno, A., Camara, R. D. L., Alvárez, A. F., Aguadol, B., Morell, A., Ramírez, E., Zurriaga, A. I., Abanades, M. P., García, S. R., Aranda, T. G., Ruiz, M., Nieto, C. M., Serra, J. M., Sánchez-Madrid, F., Muñoz-Calleja, C., Alfranca, A., Aspa, J., Marcos-Jiménez, A., Sánchez-Alonso, S., Alcaraz-Serna, A., Mateu-Albero, T., Sánchez-Cerrillo, I., Esparcia, L., Martínez-Fleta, P., López-Sanz, C., Gabrie, L., Guerola, L. D. C., Fernández, E., Calzada, M. J., Tejedor, R., Canabal, A., Albert, P., Rodríguez-Serrano, D. A., Iglesias, J., Suarez, F., Sánchez, J. A., Abad, B., Suarez, C., Santos, I. D. L., Galván-Román, J. M., Roy, E., Rodríguez-Cortes, P., García-Fraile, L., Sanz, J., Sanchez, E., Moldenhauer, F., Casado, P., Curbelo, J., Gutierrez, A., Bautista, A., Giménez, N. R., Fernandez, A., Parra, P., Moyano, B., Barrios, A., Real de Asua, D., Sanchez, B., Saez, C., Ciudad, M., Navas, D., Domingo, L. C., Torresano, M. D. C. C., García, D. D., Cavero, T. A., Blanco, A. G., Ramírez, A. M., Semiglia Chong, M. A., Cobos, A. G., Zurita Cruz, N. D., Fraile Torres, A. M., Sanchez-Gonzalez, C., Perpén, A. F., Pérez, C. D., Ancochea, J., Alonso, T., Landete, P., Soriano, J., Cisneros, C., Castillo, E. G., García Pérez, F. J., Girón, R. M., Marcos, C., Zamora, E., García, P. G., Castañeda, S., García-Vicuña, R., González-Álvaro, I., Rodríguez-García, S., Fernández-Díaz, C., Cubas, I. L., Tomero, E. G., Castañeda, N. G., Ortiz, A. M., Valero, C., Uriarte, M., & Montes, N.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 147
- Issue
- 1
- Pages
- 72-80.e8
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W3091337946
- Cited by
- 220
- References
- 5
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.